SCHEMBL843396

SCHEMBL843396

Cc1cccc(-c2nc(CCCC(C)(C)C)no2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 9/20 0.49
NPC1 O15118 9/20 0.49
GRM5 P41594 1/20 0.46
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
KDM4E B2RXH2 3/20 0.45
HSD17B10 Q99714 3/20 0.45
TSHR P16473 3/20 0.45
CASP3 P42574 2/20 0.45
SENP7 Q9BQF6 2/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
TP53 P04637 2/20 0.45
HPGD P15428 3/20 0.45
MAPT P10636 1/20 0.45
PKM P14618 1/20 0.45
POLB P06746 1/20 0.44
GAA P10253 1/20 0.43
LMNA P02545 1/20 0.41
HDAC1 Q13547 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL843409 0.83 MAPT (0.49) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL514236 0.79 RAB9A (0.57) RAB9ANPC1GRM5ALDH1A1SMN1; SMN2
SCHEMBL23986463 0.79 RAB9A (0.57) RAB9ANPC1GRM5ALDH1A1SMN1; SMN2
SCHEMBL4106551 0.77 NOTUM (0.66) RAB9ANPC1GRM5ALDH1A1SMN1; SMN2
SCHEMBL1545210 0.77 RAB9A (0.56) RAB9ANPC1GRM5ALDH1A1SMN1; SMN2
SCHEMBL16284866 0.76 NPC1 (0.65) RAB9ANPC1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL26251826 0.76 RAB9A (0.57) RAB9ANPC1GRM5ALDH1A1SMN1; SMN2
SCHEMBL4101465 0.75 RAB9A (0.48) RAB9ANPC1GRM5ALDH1A1SMN1; SMN2
SCHEMBL12694 0.75 RAB9A (0.54) RAB9ANPC1GRM5ALDH1A1SMN1; SMN2
SCHEMBL13046 0.75 RAB9A (0.56) RAB9ANPC1GRM5ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143264-B2 Xanthine derivatives as selective HM74A agonists GLAXOSMITHKLINE LLC (US) 2012-03-27 US disclosed
US-8143264-B2 Xanthine derivatives as selective HM74A agonists GLAXOSMITHKLINE LLC (US) 2012-03-27 US disclosed
US-20110257205-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GLAXOSMITHKLINE LLC 2011-10-20 US disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION 2010-07-15 US disclosed
US-20100168122-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2010-07-01 US disclosed
US-20100168122-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168122-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GPR84, XDH, GPR88 RAB9A 1775/4885NPC1 962/4885GRM5 447/4885
US-20110257205-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS GPR84, GPR88, XDH RAB9A 1905/4885NPC1 1312/4885GRM5 372/4885
US-20100179128-A1 XANTHINE DERIVATIVES AS SELECTIVE HM74A AGONISTS XDH, GPR84, GPR88 RAB9A 1728/4885NPC1 919/4885GRM5 439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.